ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` P Table_1 5 5 Continuous variables Median (range) Age (years) 45 (18 - 65)- Duration of symptoms before treatment (weeks)
3 (0.4 - 104) Follow-up (months) 3 (0.5 - 28) BCVA at presentation * 1 (0.2-2) BCVA at the end of follow-up * 0.2 (0-2) Categorical variables n (%) Male sex
35 (66.0%) HIV-positive
10 (18.9%) Bilateral ocular syphilis
36 (68.0%) Serum VDRL ≥ 1:32
45 (84.9%) CSF abnormal
39 (73.6%) Syphilis stage Primary 0 (0%) Secondary 6 (11.3%) Early latent 5 (9.4%) Late latent
42 (79.2%)+ Clinical Manifestation *# Optic neuritis
45 (51.7%) Uveitis
42 (48.2%) Anterior 2 (4.8% of uveitis) Intermediate 3 (7.1% of uveitis) Posterior 27 (64.3% of uveitis)
Panuveitis 10 (23.8% of uveitis) Antibiotic therapy Penicillin G
12 (22.6%) Ceftriaxone
40 (75.5%) Doxycycline 1 (1.9%)
d MbP?_ % * + &P &F